# AI-Enhanced Blood Pressure Monitoring System

![Python](https://img.shields.io/badge/Python-3.8%2B-blue) ![Scikit-learn](https://img.shields.io/badge/Scikit--learn-Latest-orange) ![TensorFlow](https://img.shields.io/badge/TensorFlow-2.x-red)

A comprehensive machine learning system for cuffless blood pressure estimation and cardiovascular disease (CVD) risk assessment using physiological signal processing. This project was developed as part of a Master's Group Design Project at the University of Southampton (2024-2025).

## üéì Project Overview

This MEng Group Design Project investigates data processing components for a wearable blood pressure monitoring system. The project focuses on two key areas:
1. **CVD Risk Assessment**: Machine learning model achieving 78.66% accuracy
2. **Cuffless Blood Pressure Estimation**: Achieving R¬≤ scores of 0.824 (systolic) and 0.733 (diastolic)

The system processes pressure pulse wave signals from piezoresistive sensors to provide continuous, non-invasive blood pressure monitoring enhanced by artificial intelligence.

### Key Features

- **Dual ML Systems**: CVD risk prediction and blood pressure estimation
- **Advanced Signal Processing**: Butterworth bandpass filtering (0.5-3 Hz) with zero-phase distortion
- **Clinical-Grade Performance**: Mean errors below 5 mmHg for blood pressure estimation
- **Robust Preprocessing**: Comprehensive noise simulation and reduction techniques
- **SMOTE Implementation**: Addresses class imbalance in cardiovascular datasets
- **Multi-Model Ensemble**: Random Forest, XGBoost, and Gradient Boosting

## üìä Results Summary

### Blood Pressure Estimation Performance

| Metric | Systolic BP | Diastolic BP |
|--------|-------------|---------------|
| **R¬≤ Score** | 0.824 | 0.733 |
| **Mean Error** | 2.300 ¬± 0.076 mmHg | 1.391 ¬± 0.034 mmHg |
| **Within 5 mmHg** | >85% | >85% |

### CVD Risk Assessment Performance

| Model | Accuracy |
|-------|----------|
| **Random Forest** | 78.77% |
| **XGBoost** | 78.66% |
| **Gradient Boosting** | 73.70% |

## üõ†Ô∏è Technical Architecture

### 1. Blood Pressure Estimation System

#### Signal Processing Pipeline
- **Noise Simulation**: Gaussian (œÉ=0.015), Uniform (0.001-0.015V), Mains interference (50 Hz, 0.005V)
- **Filtering**: Butterworth bandpass filter (0.5-3 Hz) with forward-backward technique
- **Feature Extraction**: 21 morphological features from pulse waveforms
  - Systolic/diastolic peaks and timing
  - Dicrotic notch characteristics
  - Pulse width and area under curve
  - Rise/fall time ratios

#### Machine Learning Models
- **Random Forest Regressor**: Primary model for BP estimation
- **Gradient Boosting Regression**: Enhanced performance on medical datasets
- **AdaBoost Regression**: Robustness to signal variations

### 2. CVD Risk Assessment System

#### Data Processing
- **Dataset**: Framingham Heart Study (4,238 participants)
- **Class Balancing**: SMOTE (Synthetic Minority Over-sampling Technique)
- **Feature Engineering**: Blood pressure, BMI, heart rate, smoking status, lipid profiles

#### Classification Models
- **Random Forest Classifier** (78.77% accuracy)
- **XGBoost** (78.66% accuracy) 
- **Gradient Boosting** (73.70% accuracy)

## üíæ Datasets

### MIMIC-III Waveform Database
- **Source**: PhysioNet
- **Size**: 40,000+ ICU patients
- **Usage**: Blood pressure estimation
- **Preprocessing**: High-fidelity ABP waveform extraction and quality filtering

### Framingham Heart Study
- **Source**: Kaggle
- **Size**: 4,238 participants
- **Usage**: CVD risk assessment
- **Features**: 10-year cardiovascular event tracking with comprehensive risk factors

## ‚öôÔ∏è Installation

### Prerequisites
```
Python 3.8+
NumPy
Pandas
Scikit-learn
SciPy
Matplotlib
Seaborn
imbalanced-learn (for SMOTE)
```

### Setup

1. Clone the repository:
```bash
git clone https://github.com/mukilan2101/AI-Enhanced-Blood-Pressure-Monitoring.git
cd AI-Enhanced-Blood-Pressure-Monitoring
```

2. Install dependencies:
```bash
pip install -r requirements.txt
```

3. Download datasets:
- MIMIC-III: Register at PhysioNet and complete required training
- Framingham: Available on Kaggle

## üöÄ Usage

### Blood Pressure Estimation

```python
from bp_estimation import WaveformProcessor, BPPredictor

# Initialize processor
processor = WaveformProcessor()

# Load and process waveform
waveform = processor.load_waveform('path/to/data')
processed = processor.apply_filtering(waveform)
features = processor.extract_features(processed)

# Predict blood pressure
predictor = BPPredictor()
sbp, dbp = predictor.predict(features)
print(f"Systolic: {sbp:.1f} mmHg, Diastolic: {dbp:.1f} mmHg")
```

### CVD Risk Assessment

```python
from cvd_risk import CVDRiskAssessor

# Initialize assessor
assessor = CVDRiskAssessor()

# Prepare patient data
patient_data = {
    'age': 55,
    'sex': 1,
    'sbp': 140,
    'dbp': 90,
    'bmi': 28.5,
    # ... additional features
}

# Assess risk
risk_score = assessor.predict_risk(patient_data)
print(f"10-year CVD Risk: {risk_score:.2%}")
```

## üìà Key Findings

### 1. Signal Processing Innovations
- Zero-phase Butterworth filtering preserves waveform morphology
- Comprehensive noise simulation improves real-world robustness
- 40% reduction in noise-related errors compared to unfiltered signals
- 95% accuracy in feature detection under severe noise conditions

### 2. SMOTE Effectiveness
- Improved CVD model accuracy from 65% to 78.66%
- Enhanced sensitivity for minority class (CVD cases)
- Maintained specificity while improving recall

### 3. Clinical Validation
- Blood pressure estimates meet ANSI/AAMI/ISO 81060-2:2019 standards
- Mean absolute errors within clinical acceptance thresholds
- Bland-Altman analysis confirms systematic agreement

### 4. Multi-Model Approach
- Ensemble methods consistently outperform single models
- Feature importance rankings provide clinical interpretability
- Cross-validation confirms robustness across patient populations

## üìÅ Project Structure

```
AI-Enhanced-Blood-Pressure-Monitoring/
‚îú‚îÄ‚îÄ AI models/
‚îÇ   ‚îú‚îÄ‚îÄ CVD risk predication model/
‚îÇ   ‚îî‚îÄ‚îÄ BP prediction model/
‚îú‚îÄ‚îÄ Individual_Design_Report.pdf
‚îú‚îÄ‚îÄ GDPgroup12_FinalReport_compressed.pdf
‚îú‚îÄ‚îÄ GDPgroup12_ProjectSpec.pdf
‚îú‚îÄ‚îÄ README.md
‚îî‚îÄ‚îÄ requirements.txt
```

## üìù Research Methodology

### Development Process
1. **Literature Review**: Investigated cuffless BP monitoring techniques
2. **Dataset Selection**: Evaluated and obtained MIMIC-III and Framingham datasets
3. **Signal Processing**: Developed filtering and feature extraction pipeline
4. **Model Development**: Implemented and compared multiple ML architectures
5. **Validation**: Clinical-standard performance evaluation

### Key Technical Decisions
- **Piezoresistive sensors**: Chosen over PPG for reduced power consumption
- **Butterworth filter**: Selected for flat passband response
- **SMOTE**: Addressed critical class imbalance in medical data
- **Ensemble methods**: Provided superior performance and interpretability

## üîÆ Future Work

- **Multi-Signal Integration**: Combine ECG and PPG with pressure signals
- **Real-Time Optimization**: Reduce processing latency below 100ms
- **Memory Optimization**: Target 256MB usage for embedded deployment
- **Embedded Deployment**: Optimize for medical-grade wearable devices
- **Irregular Rhythm Handling**: Improve accuracy in arrhythmic cases (15-20% potential improvement)
- **Extended Validation**: Test with diverse patient demographics

## ‚ö†Ô∏è Limitations

- Development used MIMIC-III ABP signals (not piezoresistive sensor data)
- Limited testing on diverse patient populations
- Real-time performance not yet evaluated on embedded hardware
- Irregular cardiac rhythms may affect accuracy
- Requires further clinical validation for medical device approval

## üéØ Applications

- **Wearable Health Monitoring**: Continuous BP tracking in daily life
- **Cardiovascular Risk Screening**: Early detection of CVD risk factors
- **Clinical Research**: Long-term BP trend analysis
- **Telemedicine**: Remote patient monitoring
- **Preventive Healthcare**: Proactive intervention strategies

## üë• Team

**Group 12 - University of Southampton MEng Project (2024-2025)**

**Data Processing & AI Lead**: Mukilan Rajapandian
- CVD Risk Assessment Model Development
- Blood Pressure Estimation System
- Signal Processing Pipeline Implementation
- Machine Learning Model Optimization

**Academic Supervisors**: 
- Dr Rujie Sun (DHBE, University of Southampton)
- Professor Kai Yang (WSA, Customer)

**Full Team**:
- Oscar Robinson (Project Manager, Sensors)
- Mikayla Colegrave (Ethics, Sensors)
- Luqmanul Mohd Awallizam (Communications)
- Geethaartha Vagga (Mobile App Development)
- Mukilan Rajapandian (Data Analysis & ML/AI)

## üôè Acknowledgments

- University of Southampton for project supervision
- PhysioNet for MIMIC-III database access
- Framingham Heart Study and Kaggle for CVD dataset
- All team members for collaborative development

## üìö References

1. Liu et al., "Cuffless Blood Pressure Estimation Using Pressure Pulse Wave Signals", Sensors, 2018
2. Huang et al., "A Highly Sensitive Pressure-Sensing Array for Blood Pressure Estimation", Sensors, 2019
3. MIMIC-III Waveform Database, PhysioNet, 2020
4. Framingham Heart Study Dataset, Kaggle
5. ANSI/AAMI/ISO 81060-2:2019 Standards

For complete references, see Individual_Design_Report.pdf and GDPgroup12_FinalReport_compressed.pdf.

## üí¨ Citation

If you use this work in your research, please cite:

```bibtex
@misc{mukilan2025bpmonitoring,
  author = {Mukilan Rajapandian and Team},
  title = {AI-Enhanced Blood Pressure Monitoring System},
  year = {2025},
  publisher = {GitHub},
  journal = {GitHub repository},
  howpublished = {\url{https://github.com/mukilan2101/AI-Enhanced-Blood-Pressure-Monitoring}}
}
```

## üìÑ License

This project is part of an academic group design project at the University of Southampton. For production deployment, additional safety measures, testing, regulatory compliance, and appropriate licensing are required.

---

**Note**: This system is designed for research and educational purposes. Clinical deployment requires extensive validation, regulatory approval, and compliance with medical device standards.
